Results 31 to 40 of about 218,382 (265)

Testing Efficacy in Determination of Recurrent Supraventricular Tachycardia among Subjectively Symptomatic Children Following “Successful” Ablation [PDF]

, 2014
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/108265/1/pace12373 ...
Bhat, Deepti P., Du, Wei, Karpawich, Peter P.   +2 more
core   +1 more source

Successful Identification of and Discrimination Between Atrial and Ventricular Arrhythmia with the Aid of Pacing and Defibrillator Devices

Arrhythmia & Electrophysiology Review, 2021
The presence of supraventricular tachycardia is the leading cause of inappropriate shock in ICD recipients, and it can be a significant cause of morbidity, psychological distress and worsened clinical outcome. Modern pacing and ICD systems offer a number
R. Mukherjee, M. Sohal, N. Shanmugam, Simon Pearse, Fadi Jouhra   +4 more
semanticscholar   +1 more source

Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. [PDF]

, 2017
Aims: To conduct a randomized trial in order to guide the optimum therapy of symptomatic atrioventricular nodal re-entrant tachycardia (AVNRT).
Camm, AJ, Giazitzoglou, E, Josephson, ME, Katritsis, DG, Katritsis, GD, Paxinos, G, Vachliotis, V, Zografos, T   +7 more
core   +1 more source

Non-pharmacological treatment of supraventricular arrhythmias [PDF]

European Heart Journal, 1996
In recent years the recognition of toxicity and relative ineffectiveness of antiarrhythmic drugs in the management of arrhythmias has led to the development of non-pharmacological approaches. In the setting of supraventricular arrhythmias, such non-pharmacological approaches include preventative pacing, atrial defibrillation, surgery and radiofrequency
V. H. Schibgilla, Mark E. Josephson
openaire   +3 more sources

Levosimendan for the prevention of acute organ dysfunction in sepsis [PDF]

, 2016
BACKGROUND Levosimendan is a calcium-sensitizing drug with inotropic and other properties that may improve outcomes in patients with sepsis. METHODS We conducted a double-blind, randomized clinical trial to investigate whether levosimendan reduces the ...
Al-Beidh, F, Ashby, D, Best-Lane, J, Brealey, D, Breen, A, Cross, M, Gordon, AC, Liu, KD, Mason, AJ, McAuley, DF, McNamee, JJ, Nutt, CL, Orme, RML, Perkins, GD, Reschreiter, H, Santhakumaran, S, Singer, M   +16 more
core   +2 more sources

Pathophysiology, diagnosis and treatment of tachycardiomyopathy. [PDF]

, 2017
Tachycardiomyopathies (TCMP) are an important cause of left ventricular (LV) dysfunction that should be recognised by physicians as they are potentially reversible and have a significant impact on morbidity and prognosis.
Lambiase, PD, Martin, CA
core   +1 more source

Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial [PDF]

, 2017
Introduction Several retrospective or single-centrestudies demonstrated the efficacy of transplacentaltreatment of fetal tachyarrhythmias. Our retrospectivenationwide survey showed that the fetal therapy willbe successful at an overall rate of 90%.
Hagiwara Akiko, Hamasaki Toshimitsu, Horigome Hitoshi, Ikeda Tomoaki, Inamura Noboru, Kato Hitoshi, Katsuragi Shinji, Kawataki Motoyoshi, Maeno Yasuki, Miyoshi Takekazu, Nii Masaki, Sago Haruhiko, Sakaguchi Heima, Shimizu Wataru, Shiraishi Isao, Shozu Makio, Taketazu Mio, Ueda Keiko, Yamamoto Haruko, Yasukochi Satoshi, Yoda Hitoshi, 堀米 仁志   +21 more
core   +1 more source

Management of Cardiovascular Health Issues in Turner Syndrome: Expert Insights and Expanded Recommendations From the 2024 Guideline Development Team

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Turner syndrome (TS) is frequently complicated by congenital heart disease (CHD). While left‐sided lesions such as bicuspid aortic valve (BAV) and coarctation of the aorta are the most common structural heart lesions in TS, other anomalies, such as aortic arch malformations, hypoplastic left heart syndrome (HLHS), persistent left superior vena
Katya de Groote, Sheetal R. Patel, Kristian Havmand Mortensen, Isabel Witvrouwen, Anthonie Duijnhouwer, Nicole M. Brown, Jasmine Grewal, Kathryn C. Chatfield, Aaron T. Dorfman, Siddharth K. Prakash   +9 more
wiley   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Pacemaker Prevention Therapy in Drug–refractory Paroxysmal Atrial Fibrillation: Reliability of Diagnostics and Effectiveness of Prevention Pacing Therapy in Vitatron™ Selection® device [PDF]

, 2006
Introduction. Atrial fibrillation (AF), the most common and rising disorder of cardiac rhythm, is quite difficult to control and/or to treat. Non pharmacological therapies for AF may involve the use of dedicated pacing algorithms to detect and prevent ...
Dell’Orto, Simonetta, Greco, Enrico Maria, Terranova, Paolo, Terranova, Peppino, Valli, Paolo   +4 more
core   +2 more sources